GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 34 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $38,366 | -29.0% | 16,681 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $54,000 | -50.9% | 16,681 | -16.4% | 0.00% | -33.3% |
| Q2 2022 | $110,000 | +134.0% | 19,961 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $47,000 | -38.2% | 19,961 | +58.0% | 0.00% | -50.0% |
| Q4 2021 | $76,000 | -66.7% | 12,630 | -23.3% | 0.00% | -71.4% |
| Q3 2021 | $228,000 | – | 16,468 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|